Quanta Dialysis Technologies

Quanta Dialysis Technologies is a private medical device company transforming kidney care with its versatile, all-in-one hemodialysis system. Its FDA-cleared platform uniquely supports Home Hemodialysis (HHD), In-Center Hemodialysis (IHD), Sustained Low-Efficiency Dialysis (SLED), and Continuous Renal Replacement Therapy (CRRT) without the need for dialysate bags, addressing critical needs for flexibility, simplicity, and portability. With strategic partnerships and a focus on the high-growth home dialysis market, Quanta is positioned to capture significant market share by reducing treatment complexity for patients and healthcare systems. The company is in the commercial stage, generating revenue through device sales and disposables.

The Quanta Dialysis System is a versatile, all-in-one hemodialysis platform featuring on-demand, bagless dialysate generation. It is a compact, portable device capable of delivering all major dialysis modalities (IHD, SLED, CRRT, HHD) with a wide dialysate flow range (50-500 mL/min), intuitive touchscreen operation, and minimal maintenance requirements (no daily chemical disinfection).

Quanta competes in the hemodialysis equipment market, which is dominated by Fresenius Medical Care and Baxter. Its primary competitive advantages are its unique all-in-one modality platform, bagless operation, and compact design tailored for home and acute care. It positions itself as a modern, flexible alternative to the larger, more traditional and complex systems offered by the incumbents.